Ivana Krajsová

机构：Ocní klinika, General University Hospital in Prague · ORCID：0000-0002-1599-6424

发表论文 96 篇 · 总被引 6203 次 · h-index 22

代表论文

COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma (2024 · European Journal of Cancer · 被引 78)
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) (2025 · Journal of Clinical Oncology · 被引 9)
1113P COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib (enco) + binimetinib (bini) vs vemurafenib (vemu) or enco in patients (pts) with BRAF V600–mutant melanoma (2023 · Annals of Oncology · 被引 7)
An update on access to novel treatment for metastatic melanoma in Europe — A 2024 survey of the European melanoma registry and the European association of dermato-oncology (2024 · European Journal of Cancer · 被引 5)
Phase III randomized trial evaluating tilsotolimod in combination with ipilimumab versus ipilimumab alone in patients with advanced refractory melanoma (ILLUMINATE 301). (2024 · Journal of Clinical Oncology · 被引 4)
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K–Mutant Advanced or Metastatic Melanoma (2026 · Clinical Cancer Research · 被引 3)